Hillary Clinton’s Not-So-Tough Talk About Wall Street Reform
As a United States senator during the crisis years, Clinton’s legislative proposals to reform banking and housing finance didn’t gain traction.
The FDA Examines Whether MRI Drugs Accumulate in Brain Tissue
The agency says doctors should consider limiting MRIs to reduce exposure from certain image-enhancing drugs that contain the metal gadolinium.
Is AT&T Overcharging Schools for Internet Service?
A lawsuit can proceed against the company for allegedly failing to offer the required discounts to schools and libraries, says an appeals court.
Are MRIs Leaving Toxic Traces in the Brain?
Researchers raise alarms about unknown health risks of GE’s Omniscan and Bayer’s Magnevist, drugs injected to get better MRI pictures that contain the heavy metal gadolinium.
This Isn’t the First Time: Hillary Clinton’s Top Five Clashes Over Secrecy
The latest flap over her private emails as secretary of state is far from the first time she’s been accused of lacking transparency.
Hillary Clinton’s Email Scandal Looks a Lot Like the Whitewater Investigation of 20 Years Ago
Hillary Clinton’s defense of her use of personal emails while she was secretary of state triggers memories of the "pink press conference."
In Papers Never Meant to Be Made Public, Tim Geithner Really Opens Up
The former Treasury secretary and architect of the Obama administration’s financial rescue sounds more like some of his detractors when writing candidly.
All the Things Hillary Clinton’s Book Doesn’t Say About Iraq
In Hard Choices, the former secretary of state ignores or glosses over key aspects of her record on Iraq—including State Department responsibility for the country’s security assistance.
Timothy Geithner: ‘I Should Have Paid More Attention’ to Citigroup’s Woes
The former treasury secretary says his close ties to ex-Citi executive Robert Rubin "tempered my skepticism" about the bank’s health in the years before the financial crisis hit.